Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology

P. J. Helms, S. Ekins-Daukes, Michael William Taylor, Colin Richard Simpson, James Stuart McLay

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background

The majority of medicines prescribed for children are prescribed in primary care for common acute and chronic conditions. This is in contrast to prescribing in secondary care where the population of children admitted is small but where a large number of different medicines are prescribed to treat more serious and less common conditions.

Methods

Data on prescribing was extracted from the General Practice Administration System for Scotland (GPASS) for the year November 1999 to October 2000 and prescribing patterns for children aged 0-16 years expressed as percentages. A comparison of age specific consultations for asthma, as an example of a common paediatric condition, was also made between two separate general practice data sets, the General Practice Research Database (GRPD) and the continuous morbidity recording (CMR) subset of GPASS.

Results

Of 214 medicines investigated for unlicensed and off-label prescribing no unlicensed prescribing was identified. Off-label prescribing due to age was most common among younger and older children. The most common reasons for off-label prescriptions were, in order of frequency, lower than recommended dose, higher than recommended dose, below the recommended age, and unlicensed formulation. Age and gender specific consultations for asthma were similar in the two representative databases, GPRD and CMR, both showing disappearance of the male predominance in the teenage years.

Conclusions

Large primary care data sets available within a unified health care system such as the UK National Health Service (NHS) are likely to be broadly compatible and produce similar results. The prescribing of off-label medicines to children is common in primary care, most commonly due to prescribing out with the recommended dosage regimen.

Original languageEnglish
Pages (from-to)684-690
Number of pages7
JournalBritish Journal of Clinical Pharmacology
Volume59
Issue number6
Early online date6 May 2005
DOIs
Publication statusPublished - Jun 2005

Keywords

  • children
  • medicines
  • prescribing disease epidemiology
  • primary care
  • general-practice
  • Danish children
  • drug-use
  • prescription
  • morbidity

Cite this

Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology. / Helms, P. J.; Ekins-Daukes, S.; Taylor, Michael William; Simpson, Colin Richard; McLay, James Stuart.

In: British Journal of Clinical Pharmacology, Vol. 59, No. 6, 06.2005, p. 684-690.

Research output: Contribution to journalArticle

Helms, P. J. ; Ekins-Daukes, S. ; Taylor, Michael William ; Simpson, Colin Richard ; McLay, James Stuart. / Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology. In: British Journal of Clinical Pharmacology. 2005 ; Vol. 59, No. 6. pp. 684-690.
@article{c058ea56ec8848189293c9fb16b5eb75,
title = "Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology",
abstract = "BackgroundThe majority of medicines prescribed for children are prescribed in primary care for common acute and chronic conditions. This is in contrast to prescribing in secondary care where the population of children admitted is small but where a large number of different medicines are prescribed to treat more serious and less common conditions.MethodsData on prescribing was extracted from the General Practice Administration System for Scotland (GPASS) for the year November 1999 to October 2000 and prescribing patterns for children aged 0-16 years expressed as percentages. A comparison of age specific consultations for asthma, as an example of a common paediatric condition, was also made between two separate general practice data sets, the General Practice Research Database (GRPD) and the continuous morbidity recording (CMR) subset of GPASS.ResultsOf 214 medicines investigated for unlicensed and off-label prescribing no unlicensed prescribing was identified. Off-label prescribing due to age was most common among younger and older children. The most common reasons for off-label prescriptions were, in order of frequency, lower than recommended dose, higher than recommended dose, below the recommended age, and unlicensed formulation. Age and gender specific consultations for asthma were similar in the two representative databases, GPRD and CMR, both showing disappearance of the male predominance in the teenage years.ConclusionsLarge primary care data sets available within a unified health care system such as the UK National Health Service (NHS) are likely to be broadly compatible and produce similar results. The prescribing of off-label medicines to children is common in primary care, most commonly due to prescribing out with the recommended dosage regimen.",
keywords = "children, medicines, prescribing disease epidemiology, primary care, general-practice, Danish children, drug-use, prescription, morbidity",
author = "Helms, {P. J.} and S. Ekins-Daukes and Taylor, {Michael William} and Simpson, {Colin Richard} and McLay, {James Stuart}",
year = "2005",
month = "6",
doi = "10.1111/j.1365-2125.2005.02404.x",
language = "English",
volume = "59",
pages = "684--690",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology

AU - Helms, P. J.

AU - Ekins-Daukes, S.

AU - Taylor, Michael William

AU - Simpson, Colin Richard

AU - McLay, James Stuart

PY - 2005/6

Y1 - 2005/6

N2 - BackgroundThe majority of medicines prescribed for children are prescribed in primary care for common acute and chronic conditions. This is in contrast to prescribing in secondary care where the population of children admitted is small but where a large number of different medicines are prescribed to treat more serious and less common conditions.MethodsData on prescribing was extracted from the General Practice Administration System for Scotland (GPASS) for the year November 1999 to October 2000 and prescribing patterns for children aged 0-16 years expressed as percentages. A comparison of age specific consultations for asthma, as an example of a common paediatric condition, was also made between two separate general practice data sets, the General Practice Research Database (GRPD) and the continuous morbidity recording (CMR) subset of GPASS.ResultsOf 214 medicines investigated for unlicensed and off-label prescribing no unlicensed prescribing was identified. Off-label prescribing due to age was most common among younger and older children. The most common reasons for off-label prescriptions were, in order of frequency, lower than recommended dose, higher than recommended dose, below the recommended age, and unlicensed formulation. Age and gender specific consultations for asthma were similar in the two representative databases, GPRD and CMR, both showing disappearance of the male predominance in the teenage years.ConclusionsLarge primary care data sets available within a unified health care system such as the UK National Health Service (NHS) are likely to be broadly compatible and produce similar results. The prescribing of off-label medicines to children is common in primary care, most commonly due to prescribing out with the recommended dosage regimen.

AB - BackgroundThe majority of medicines prescribed for children are prescribed in primary care for common acute and chronic conditions. This is in contrast to prescribing in secondary care where the population of children admitted is small but where a large number of different medicines are prescribed to treat more serious and less common conditions.MethodsData on prescribing was extracted from the General Practice Administration System for Scotland (GPASS) for the year November 1999 to October 2000 and prescribing patterns for children aged 0-16 years expressed as percentages. A comparison of age specific consultations for asthma, as an example of a common paediatric condition, was also made between two separate general practice data sets, the General Practice Research Database (GRPD) and the continuous morbidity recording (CMR) subset of GPASS.ResultsOf 214 medicines investigated for unlicensed and off-label prescribing no unlicensed prescribing was identified. Off-label prescribing due to age was most common among younger and older children. The most common reasons for off-label prescriptions were, in order of frequency, lower than recommended dose, higher than recommended dose, below the recommended age, and unlicensed formulation. Age and gender specific consultations for asthma were similar in the two representative databases, GPRD and CMR, both showing disappearance of the male predominance in the teenage years.ConclusionsLarge primary care data sets available within a unified health care system such as the UK National Health Service (NHS) are likely to be broadly compatible and produce similar results. The prescribing of off-label medicines to children is common in primary care, most commonly due to prescribing out with the recommended dosage regimen.

KW - children

KW - medicines

KW - prescribing disease epidemiology

KW - primary care

KW - general-practice

KW - Danish children

KW - drug-use

KW - prescription

KW - morbidity

U2 - 10.1111/j.1365-2125.2005.02404.x

DO - 10.1111/j.1365-2125.2005.02404.x

M3 - Article

VL - 59

SP - 684

EP - 690

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 6

ER -